IL129141A0 - Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis - Google Patents

Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis

Info

Publication number
IL129141A0
IL129141A0 IL12914197A IL12914197A IL129141A0 IL 129141 A0 IL129141 A0 IL 129141A0 IL 12914197 A IL12914197 A IL 12914197A IL 12914197 A IL12914197 A IL 12914197A IL 129141 A0 IL129141 A0 IL 129141A0
Authority
IL
Israel
Prior art keywords
pyridone
hydroxy
treatment
seborrheic dermatitis
seborrheic
Prior art date
Application number
IL12914197A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL129141A0 publication Critical patent/IL129141A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
IL12914197A 1996-09-27 1997-09-16 Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis IL129141A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19639818A DE19639818A1 (de) 1996-09-27 1996-09-27 Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis
PCT/EP1997/005070 WO1998013009A2 (fr) 1996-09-27 1997-09-16 Utilisation de 1-hydroxy-2-pyridone pour le traitement de l'eczema seborrheique

Publications (1)

Publication Number Publication Date
IL129141A0 true IL129141A0 (en) 2000-02-17

Family

ID=7807118

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12914197A IL129141A0 (en) 1996-09-27 1997-09-16 Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis

Country Status (32)

Country Link
EP (1) EP0928183B1 (fr)
JP (2) JP2001500884A (fr)
KR (1) KR100494207B1 (fr)
CN (1) CN1104231C (fr)
AR (1) AR008860A1 (fr)
AT (1) ATE209891T1 (fr)
AU (1) AU716208B2 (fr)
BG (1) BG64365B1 (fr)
BR (1) BR9711575A (fr)
CA (1) CA2267165C (fr)
CY (1) CY2362B1 (fr)
CZ (1) CZ291485B6 (fr)
DE (2) DE19639818A1 (fr)
DK (1) DK0928183T3 (fr)
ES (1) ES2167721T3 (fr)
HK (1) HK1022267A1 (fr)
HU (1) HU226955B1 (fr)
ID (1) ID21874A (fr)
IL (1) IL129141A0 (fr)
MA (1) MA24333A1 (fr)
MY (1) MY125674A (fr)
NO (1) NO312492B1 (fr)
NZ (1) NZ334850A (fr)
OA (1) OA11028A (fr)
PL (1) PL188033B1 (fr)
PT (1) PT928183E (fr)
RS (1) RS49801B (fr)
TR (1) TR199900662T2 (fr)
TW (1) TW519491B (fr)
UA (1) UA57754C2 (fr)
WO (1) WO1998013009A2 (fr)
ZA (1) ZA978640B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
EP2197440B1 (fr) 2007-08-31 2012-12-26 Janssen Pharmaceutica, N.V. Combinaisons d'imazalil et d'hydroxypyridones
CN101877968A (zh) 2007-11-30 2010-11-03 詹森药业有限公司 杀真菌的吡咯化合物和pyrion化合物的组合
CA2711762C (fr) 2008-02-06 2016-11-01 Jan Pieter Hendrik Bosselaers Combinaisons de phenylpyrroles et de composes pyrion
JP5870101B2 (ja) 2010-07-01 2016-02-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ ピリオン化合物とポリエチレンイミンとの抗微生物性組み合わせ
ES2573116T3 (es) * 2010-12-02 2016-06-06 The University Of Kansas Profármacos de 6-ciclohexil-1-hidroxi-4-metilpiridin-2(1H)-ona y sus derivados
WO2013011996A1 (fr) * 2011-07-19 2013-01-24 リジェンティス株式会社 Composition de poly(acide phosphorique) contenant du poly(acide phosphorique) extrait de cellule de levure, sel de poly(acide phosphorique) ou solvate de poly(acide phosphorique), et procédé pour produire celui-ci
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CN104744359B (zh) * 2015-03-06 2017-10-10 上药康丽（常州）药业有限公司 一种环吡酮的精制方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234009C3 (de) * 1972-07-11 1979-01-11 Hoechst Ag, 6000 Frankfurt Kosmetische Zubereitungen
NL8601762A (nl) * 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
KR950702819A (ko) * 1992-09-08 1995-08-23 제이코버스 코넬리스 레이서 실질적으로 무색의 순한 샴푸 조성물(mild, substantially coloriess shampoo compostion)
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
FR2722689B1 (fr) * 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant

Also Published As

Publication number Publication date
DE19639818A1 (de) 1998-04-02
AU4774697A (en) 1998-04-17
CZ107599A3 (cs) 1999-06-16
NO991460L (no) 1999-03-25
ID21874A (id) 1999-08-05
HK1022267A1 (en) 2000-08-04
AR008860A1 (es) 2000-02-23
ATE209891T1 (de) 2001-12-15
NO991460D0 (no) 1999-03-25
CA2267165A1 (fr) 1998-04-02
AU716208B2 (en) 2000-02-24
WO1998013009A2 (fr) 1998-04-02
CA2267165C (fr) 2003-12-16
NO312492B1 (no) 2002-05-21
DK0928183T3 (da) 2002-04-02
PT928183E (pt) 2002-05-31
EP0928183B1 (fr) 2001-12-05
HUP9903811A1 (hu) 2000-04-28
OA11028A (fr) 2003-03-06
MA24333A1 (fr) 1998-04-01
CN1104231C (zh) 2003-04-02
HUP9903811A3 (en) 2001-11-28
KR20000048613A (ko) 2000-07-25
BR9711575A (pt) 1999-08-24
HU226955B1 (en) 2010-03-29
JP2001500884A (ja) 2001-01-23
EP0928183A2 (fr) 1999-07-14
CN1231595A (zh) 1999-10-13
JP2006176540A (ja) 2006-07-06
RS49801B (sr) 2008-06-05
BG103260A (en) 2000-01-31
PL332603A1 (en) 1999-09-27
CZ291485B6 (cs) 2003-03-12
YU13499A (sh) 2001-09-28
CY2362B1 (en) 2004-06-04
DE59705697D1 (de) 2002-01-17
NZ334850A (en) 2001-02-23
TR199900662T2 (xx) 1999-06-21
MY125674A (en) 2006-08-30
PL188033B1 (pl) 2004-11-30
UA57754C2 (uk) 2003-07-15
ES2167721T3 (es) 2002-05-16
TW519491B (en) 2003-02-01
KR100494207B1 (ko) 2005-06-13
WO1998013009A3 (fr) 1998-05-14
BG64365B1 (bg) 2004-12-30
ZA978640B (en) 1998-03-27

Similar Documents

Publication Publication Date Title
AU3441197A (en) 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
ZA993364B (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
PL345338A1 (en) Method for the treatment of insomnia
IL126696A0 (en) Azetidinone derivatives for the treatment of atherosclerosis
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
IL129141A0 (en) Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis
PL345769A1 (en) Triazolopyridines for the treatment of thrombosis disorders
HUP0200738A3 (en) Method of the treatment of incontinence
AU1697197A (en) Immunoconjugate for the treatment of aids
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
ZA976350B (en) Treatment of liquid.
ZA973843B (en) Treatment of asthma with TNFR-lg.
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
IL112469A0 (en) Composition for the treatment of an epidermal disorder
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
AU2510197A (en) Solid agent for the treatment of keratinous fibres
AU4032799A (en) Device for the treatment of bottles
SI0928183T1 (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
HK1043938A1 (en) Composition for the treatment of psoriasis
IL112839A0 (en) Methods for the purification of halofluorocarbons
GB9726223D0 (en) The treatment of materials
GB9420080D0 (en) The treatment of liquids
ZA978139B (en) Process for the biological-thermal treatment of waste.
ZA974386B (en) New formulation for treatment of thromboembolism.
HK1004660A1 (en) Composition for treating hyperosteogeny and process for the preparation thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired